BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 21083037)

  • 21. Lymphoplasmacytic lymphoma/immunocytoma: towards a disease-targeted treatment?
    Clavio M; Quintino S; Venturino C; Ballerini F; Varaldo R; Gatto S; Galbusera V; Garrone A; Grasso R; Canepa L; Miglino M; Pierri I; Gobbi M
    J Exp Clin Cancer Res; 2001 Sep; 20(3):351-8. PubMed ID: 11718214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current therapeutic strategies and new treatment paradigms for follicular lymphoma.
    Kritharis A; Sharma J; Evens AM
    Cancer Treat Res; 2015; 165():197-226. PubMed ID: 25655611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment strategies in advanced stage follicular lymphoma.
    van Oers MH; Kersten MJ
    Best Pract Res Clin Haematol; 2011 Jun; 24(2):187-201. PubMed ID: 21658618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of rituximab and/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study.
    Sebban C; Brice P; Delarue R; Haioun C; Souleau B; Mounier N; Brousse N; Feugier P; Tilly H; Solal-Céligny P; Coiffier B
    J Clin Oncol; 2008 Jul; 26(21):3614-20. PubMed ID: 18559872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salvage chemotherapy in follicular non-Hodgkin's lymphoma: focus on tolerability.
    Zinzani PL
    Clin Lymphoma Myeloma; 2006 Sep; 7(2):115-24. PubMed ID: 17026822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autologous stem cell transplantation in follicular non-Hodgkin's lymphoma.
    Pettengell R
    Bone Marrow Transplant; 2002 Feb; 29 Suppl 1():S1-4. PubMed ID: 11840153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiolabeled and native antibodies and the prospect of cure of follicular lymphoma.
    Buchegger F; Press OW; Delaloye AB; Ketterer N
    Oncologist; 2008 Jun; 13(6):657-67. PubMed ID: 18586921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current management of follicular lymphomas.
    Hiddemann W; Buske C; Dreyling M; Weigert O; Lenz G; Unterhalt M
    Br J Haematol; 2007 Jan; 136(2):191-202. PubMed ID: 17073892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing the treatment of patients with rituximab-pretreated recurrent indolent non-Hodgkin lymphoma.
    Leonard JP; Gregory SA; Maloney DG; Vose JM; Younes A; Zelenetz AD
    Clin Adv Hematol Oncol; 2008 Jun; 6(6):437-45. PubMed ID: 18567989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current status and perspective of antibody therapy in follicular lymphoma.
    Buske C; Weigert O; Dreyling M; Unterhalt M; Hiddemann W
    Haematologica; 2006 Jan; 91(1):104-12. PubMed ID: 16434378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cladribine combined with rituximab (R-2-CdA) therapy is an effective salvage therapy in relapsed or refractory indolent B-cell non-Hodgkin lymphoma.
    Nagai H; Ogura M; Kusumoto S; Takahashi N; Yamaguchi M; Takayama N; Kinoshita T; Motoji T; Ohyashiki K; Kosugi H; Matsuda S; Ohnishi K; Omachi K; Hotta T
    Eur J Haematol; 2011 Feb; 86(2):117-23. PubMed ID: 21070370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment approaches to asymptomatic follicular lymphoma.
    Sarkozy C; Salles G
    Expert Rev Hematol; 2013 Dec; 6(6):747-58. PubMed ID: 24219551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
    Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
    Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Recent progress in the treatment of malignant lymphoma].
    Ogura M
    Gan To Kagaku Ryoho; 2001 Sep; 28(9):1213-35. PubMed ID: 11579632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Managing newly diagnosed follicular lymphoma: state of the art and future perspectives.
    Li ZM; Ghielmini M; Moccia AA
    Expert Rev Anticancer Ther; 2013 Mar; 13(3):313-25. PubMed ID: 23477518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stem cell function and engraftment is not affected by "in vivo purging" with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphoma.
    Buckstein R; Imrie K; Spaner D; Potichnyj A; Robinson JB; Nanji S; Pennel N; Reis M; Pinkerton P; Dubé I; Hewitt K; Berinstein NL
    Semin Oncol; 1999 Oct; 26(5 Suppl 14):115-22. PubMed ID: 10561026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transplantation strategies for patients with follicular lymphoma.
    Buske C; Dreyling M; Unterhalt M; Hiddemann W
    Curr Opin Hematol; 2005 Jul; 12(4):266-72. PubMed ID: 15928482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and treatment of follicular lymphoma.
    Hitz F; Ketterer N; Lohri A; Mey U; Pederiva S; Renner C; Taverna C; Hartmann A; Yeow K; Bodis S; Zucca E
    Swiss Med Wkly; 2011; 141():w13247. PubMed ID: 21815111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of follicular lymphoma: current status.
    Tilly H; Zelenetz A
    Leuk Lymphoma; 2008; 49 Suppl 1():7-17. PubMed ID: 18821428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dose chemotherapy followed by autologous and allogeneic hematopoietic stem cell transplantation in patients with follicular non-Hodgkin’s lymphoma in the rituximab era.
    Escobar IG; Sánchez de Ibarguen BC; de Juan VC; Alonso CM; García MM; Ruíz AC; Pulla MP
    Tumori; 2015; 101(1):2-7. PubMed ID: 25702654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.